4.5 Article

High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas

出版社

WILEY
DOI: 10.1002/hed.26906

关键词

head and neck squamous cell carcinoma; human papillomavirus; NFX1-123; Notch1; oropharyngeal cancer

资金

  1. National Cancer Institute [R01 CA172742]

向作者/读者索取更多资源

The study found that NFX1-123 and a subset of its known targets were increased in HPV+ HNSCCs, while LCE1B, KRT16, SPRR2G, and FBN2 were highly expressed in HNSCCs. Notch1 and CCNB1IP1 had greater expression in HPV+ HNSCCs compared to HPV- HNSCCs.
Background High-risk human papillomaviruses (HR HPV) cause nearly all cervical cancers and, in the United States, the majority of head and neck cancers (HNSCCs). NFX1-123 is overexpressed in cervical cancers, and NFX1-123 partners with the HR HPV type 16 E6 oncoprotein to affect multiple growth, differentiation, and immune response genes. However, neither the expression of NFX1-123 nor the levels of these genes have been investigated in HPV positive (HPV+) or negative (HPV-) HNSCCs. Methods The Cancer Genome Atlas Splicing Variants Database and HNSCC cell lines were used to quantify expression of NFX1-123 and cellular genes increased in cervical cancers. Results NFX1-123 was increased in HPV+ HNSCCs compared to HPV- HNSCCs. LCE1B, KRT16, SPRR2G, and FBN2 were highly expressed in HNSCCs compared to normal tissues. Notch1 and CCNB1IP1 had greater expression in HPV+ HNSCCs compared to HPV- HNSCCs. Conclusion NFX1-123 and a subset of its known targets were increased in HPV+ HNSCCs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据